The diagnostic value of uterine spiral artery ultrasound combined with serum CTRP6 and sTWEAK for early-onset preeclampsia

doi:10.11958/20250404

Abstract

Abstract:

Objective To explore the diagnostic value of uterine spiral artery ultrasound combined with serum complement C1q tumor necrosis factor related protein 6 (CTRP6) and soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) for early-onset preeclampsia (EOPE). Methods A total of 104 pregnant women diagnosed with EOPE in early to mid pregnancy were regarded as the EOPE group, and another 104 healthy pregnant women who underwent prenatal examinations were used as the control group. ELISA was applied to measure the expression levels of serum CTRP6 and sTWEAK. Logistic regression analysis was applied to analyze factors influencing the occurrence of EOPE. The diagnostic value of serum CTRP6, sTWEAK and uterine spiral artery ultrasound parameters in EOPE was analyzed by receiver operating characteristic (ROC) curve. Results Compared with the control group, proteinuria quantification, systolic blood pressure, diastolic blood pressure and serum CTRP6 were increased in the EOPE group (P<0.05), serum sTWEAK level was decreased, and pulsatile index (PI), resistance index (RI) and peak systolic velocity/end diastolic velocity (S/D) of uterine spiral artery of pregnant women were all increased in the EOPE group (P<0.05). CTRP6, PI, RI, S/D, systolic blood pressure and diastolic blood pressure were risk factors of EOPE (P<0.05), and serum level of sTWEAK was the protective factor of EOPE (P<0.05). The combination of CTRP6, sTWEAK, PI, RI and S/D had the highest AUC in the diagnosis of EOPE, which was better than their individual diagnoses (Z=5.924, 6.583, 5.664, 5.399 and 7.627, P<0.01). Conclusion The combination of uterine spiral artery ultrasound and serum CTRP6 and sTWEAK can better diagnose the occurrence of EOPE.

Key words: eclampsia, ultrasonography, Doppler, cytokine TWEAK, complement C1q tumor necrosis factor related protein 6, uterine spiral artery ultrasound, early onset preeclampsia

CLC Number:

R714.25

Figures/Tables 6

References 25

[1]	MACDONALD T M, WALKER S P, HANNAN N J, et al. Clinical tools and biomarkers to predict preeclampsia[J]. EBioMedicine, 2022, 75:103780. doi:10.1016/j.ebiom.2021.103780.
[2]	OVERTON E, TOBES D, LEE A. Preeclampsia diagnosis and management[J]. Best Pract Res Clin Anaesthesiol, 2022, 36(1):107-121. doi:10.1016/j.bpa.2022.02.003.
[3]	ROCHA G. Consequences of early-onset preeclampsia on neonatal morbidity and mortality[J]. Minerva Pediatr(Torino), 2023, 75(1):87-97. doi:10.23736/S2724-5276.22.06714-3.
[4]	CHAEMSAITHONG P, SAHOTA D S, POON L C. First trimester preeclampsia screening and prediction[J]. Am J Obstet Gynecol, 2022, 226(2S):S1071-S1097.e2. doi:10.1016/j.ajog.2020.07.020.
[5]	GUO F, ZHANG B, YANG H, et al. Systemic transcriptome comparison between early-and late-onset pre-eclampsia shows distinct pathology and novel biomarkers[J]. Cell Prolif, 2021, 54(2):e12968. doi:10.1111/cpr.12968.
[6]	赵金珩, 王茜, 桑雪梅, 等. 联合检测血清中可溶性血管内皮生长因子受体-1、胎盘生长因子、Survivin表达水平在早发型子痫前期诊断中的价值研究[J]. 中国医师进修杂志, 2019, 42(8):727-730.
	ZHAO J H, WANG X, SANG X M, et al. The value of combined detection of soluble vascular endothelial growth factor receptor-1,placental growth factor and Survivin in the diagnosis of early-onset preeclampsia[J]. China Journal of Physician Education, 2019, 42(8):727-730. doi:10.3760/cma.j.issn.1673-4904.2019.08.015.
[7]	DE GANZO SUÁREZ T, DE PACO MATALLANA C, PLASENCIA W. Spiral,uterine artery doppler and placental ultrasound in relation to preeclampsia[J]. Best Pract Res Clin Obstet Gynaecol, 2024, 92:102426. doi:10.1016/j.bpobgyn.2023.102426.
[8]	HORGAN R, SINKOVSKAYA E, SAADE G, et al. Longitudinal assessment of spiral and uterine arteries in normal pregnancy using novel ultrasound tool[J]. Ultrasound Obstet Gynecol, 2023, 62(6):860-866. doi:10.1002/uog.26312.
[9]	LIAO X, LIU S, TANG X, et al. Circulating CTRP6 levels are increased in overweight or obese Chinese individuals and associated with insulin resistance parameters:a pilot study[J]. Exp Clin Endocrinol Diabetes, 2021, 129(7):535-541. doi:10.1055/a-0929-6072.
[10]	SHAHID S, KHALID E, FATIMA S S, et al. Evaluation of soluble TNF-like weak inducer of apoptosis(sTWEAK) levels to predict preeclampsia in early weeks of pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2019, 234:165-170. doi:10.1016/j.ejogrb.2019.01.020.
[11]	谢幸, 苟文丽. 妇产科学[M]. 8版. 北京: 人民卫生出版社, 2013:83.
	XIE X, GOU W L. Obstetrics and Gynecology[M]. 8th ed. Beijing: People's Medical Publishing House, 2013:83.
[12]	YANG Y, LE RAY I, ZHU J, et al. Preeclampsia prevalence,risk factors,and pregnancy outcomes in Sweden and China[J]. JAMA Netw Open, 2021, 4(5):e218401. doi:10.1001/jamanetworkopen.2021.8401.
[13]	JI Q, ZHANG S, JIANG W, et al. Serum protein profile analysis via label-free quantitation proteomics in patients with early-onset preeclampsia[J]. J Obstet Gynaecol, 2023, 43(2):2259982. doi:10.1080/01443615.2023.2259982.
[14]	刘晓丹, 金阳, 申雨鑫, 等. 多普勒超声监测早期先兆流产孕妇子宫螺旋动脉血流参数预测保胎预后效能[J]. 中国计划生育学杂志, 2023, 31(11):2577-2581,2586.
	LIU X D, JIN Y, SHEN Y X, et al. Doppler ultrasound monitoring uterine spiral artery blood flow parameters of pregnant women with early threatened abortion to predict the prognosis of miscarriage[J]. Chinese Journal of Family Planning, 2023, 31(11):2577-2581,2586. doi:10.3969/j.issn.1004-8189.2023.11.011.
[15]	韩清, 王英华, 薛亚丽, 等. 子宫螺旋动脉血流参数与孕妇血清胎盘生长因子对早发型子痫前期预测[J]. 中国超声医学杂志, 2016, 32(2):153-156.
	HAN Q, WANG Y H, XUE Y L, et al. Prediction of early-onset preeclampsia by uterine spiral artery blood flow parameters and maternal serum placental growth factor[J]. Chinese Journal of Ultrasound in Medicine, 2016, 32(2):153-156. doi:10.3969/j.issn.1002-0101.2016.02.022.
[16]	李倩, 雷磊, 常贝, 等. 子宫螺旋动脉超声联合血清TGF-β1、IGF-1水平预测早发型子痫前期的临床价值[J]. 中国现代医学杂志, 2020, 30(15):39-43.
	LI Q, LEI L, CHANG B, et al. Clinical value of uterine spiral artery ultrasound combined with serum TGF-β1 and IGF-1 levels in predicting early-onset preeclampsia[J]. China Journal of Modern Medicine, 2020, 30(15):39-43. doi:10.3969/j.issn.1005-8982.2020.15.007.
[17]	杨昭, 蒋佳男, 黄佳琪, 等. 高脂饮食和运动影响妊娠中期大鼠皮下和腹膜脂肪组织中asprosin和CTRP6的表达[J]. 南方医科大学学报, 2020, 40(10):1406-1414.
	YANG Z, JIANG J N, HUANG J Q, et al. High-fat diet and exercise affect the expression of asprosin and CTRP6 in subcutaneous and peritoneal adipose tissue of rats in the second trimester of pregnancy[J]. Journal of Southern Medical University, 2020, 40(10):1406-1414. doi:10.12122/j.issn.1673-4254.2020.10.05.
[18]	LAHAV R, HAIM Y, BHANDARKAR N S, et al. CTRP6 rapidly responds to acute nutritional changes,regulating adipose tissue expansion and inflammation in mice[J]. Am J Physiol Endocrinol Metab, 2021, 321(5):E702-E713. doi:10.1152/ajpendo.00299.2021.
[19]	LI Y, SUN J, GU L, et al. Protective effect of CTRP6 on cerebral ischemia/reperfusion injury by attenuating inflammation,oxidative stress and apoptosis in PC12 cells[J]. Mol Med Rep, 2020, 22(1):344-352. doi:10.3892/mmr.2020.11108.
[20]	马丽丽, 史伟, 唐田田, 等. 子痫前期患者血清CTRP6、sTNFR-Ⅱ水平及其诊断价值[J]. 中国计划生育学杂志, 2023, 31(3):662-665.
	MA L L, SHI W, TANG T T, et al. Serum CTRP6 and sTNFR-Ⅱ levels in patients with preeclampsia and their diagnostic value[J]. Chinese Journal of Family Planning, 2023, 31(3):662-665. doi:10.3969/j.issn.1004-8189.2023.03.038.
[21]	DA SILVA-CANDAL A, LÓPEZ-DEQUIDT I, RODRIGUEZ-YAÑEZ M, et al. sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage[J]. Stroke Vasc Neurol, 2021, 6(4):528-535. doi:10.1136/svn-2020-000684.
[22]	黄毓丽, 施慧, 于瑞华. sTWEAK在子痫前期患者血清中的表达及其意义[J]. 中国实验诊断学, 2022, 26(12):1754-1757.
	HUANG Y L, SHI H, YU R H. Expression and significance of sTWEAK in serum of patients with preeclampsia[J]. Chinese Journal of Laboratory Diagnosis, 2022, 26(12):1754-1757. doi:10.3969/j.issn.1007-4287.2022.12.004.
[23]	尹婧婧, 窦立冬, 王昱. T2DM患者血清sTWEAK、sCD40L水平与糖尿病微血管并发症的相关性分析[J]. 新疆医科大学学报, 2024, 47(3):383-387.
	YIN J J, DOU L D, WANG Y. Correlation analysis between serum levels of sTWEAK and sCD40L in patients with T2DM and diabetic microvascular complications[J]. Journal of Xinjiang Medical University, 2024, 47(3):383-387. doi:10.3969/j.issn.1009-5551.2024.03.014.
[24]	BRÄNN E, EDVINSSON Å, ROSTEDT PUNGA A, et al. Inflammatory and anti-inflammatory markers in plasma:from late pregnancy to early postpartum[J]. Sci Rep, 2019, 9(1):1863. doi:10.1038/s41598-018-38304-w.
[25]	ZAITSEVA O, HOFFMANN A, OTTO C, et al. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy[J]. Front Pharmacol, 2022, 13:935086. doi:10.3389/fphar.2022.935086.

组别		年龄/岁	孕周/周		产次/次		BMI/（kg/m²）
对照组		32.47±4.31	25.94±3.52		2.20±0.51		22.18±2.24
EOPE组		32.53±4.24	25.65±3.41		2.26±0.49		22.41±2.36
t		0.097	0.600		0.973		0.752
组别	尿蛋白定量/（g/24 h）			收缩压/mmHg		舒张压/mmHg
对照组	0.23±0.05			122.42±14.87		86.15±8.41
EOPE组	0.26±0.12			136.43±16.42		92.46±9.14
t	2.850^＊＊			6.450^＊＊		5.179^＊＊

组别		年龄/岁	孕周/周		产次/次		BMI/（kg/m²）
对照组		32.47±4.31	25.94±3.52		2.20±0.51		22.18±2.24
EOPE组		32.53±4.24	25.65±3.41		2.26±0.49		22.41±2.36
t		0.097	0.600		0.973		0.752
组别	尿蛋白定量/（g/24 h）			收缩压/mmHg		舒张压/mmHg
对照组	0.23±0.05			122.42±14.87		86.15±8.41
EOPE组	0.26±0.12			136.43±16.42		92.46±9.14
t	2.850^＊＊			6.450^＊＊		5.179^＊＊

组别	CTRP6	sTWEAK
对照组	12.46±2.65	10.18±2.69
EOPE组	16.25±3.16	7.74±1.97
t	9.356^＊＊	7.435^＊＊

组别	CTRP6	sTWEAK
对照组	12.46±2.65	10.18±2.69
EOPE组	16.25±3.16	7.74±1.97
t	9.356^＊＊	7.435^＊＊

组别	PI	RI	S/D
对照组	0.56±0.05	0.37±0.05	1.64±0.13
EOPE组	0.63±0.07	0.45±0.07	1.75±0.15
t	8.720^＊＊	8.975^＊＊	5.676^＊＊